| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:809.)
© 2005 American Heart Association, Inc.
Original Contributions |
From the Department of Medicine, University of Toronto (M.K.K., F.S., C.J., A.M.C.), Ontario, Canada; Department of Health Policy, Management, and Evaluation, University of Toronto (M.K.K., A.M.C.), Ontario, Canada; Institute for Clinical Evaluative Sciences (M.K.K., J.F., J.R.), Toronto, Ontario, Canada; Division of General Internal Medicine and Clinical Epidemiology, and Womens Health Program, University Health Network (M.K.K, A.M.C.), Toronto, Ontario, Canada; Division of Neurology, University Health Network (F.S., C.J.), Toronto, Ontario, Canada; and Departments of Clinical Neurosciences/Medicine/Community Health Sciences (M.D.H.), University of Calgary, Alberta, Canada.
Correspondence to Dr Moira K. Kapral, Toronto General Hospital, 200 Elizabeth St 9 Eaton S, Room 409, Toronto, Ontario, Canada M5G 2C4. E-mail moira.kapral{at}uhn.on.ca
| Abstract |
|---|
|
|
|---|
Methods The Registry of the Canadian Stroke Network (RCSN) captured data on patients with stroke seen at acute care hospitals across Canada. We used data from phase 1 (July 2001 to February 2002) and phase 2 (June to December 2002) of the RCSN to compare stroke presentation, management, and 6-month outcomes in women and men using multivariable regression techniques to adjust for age and other factors.
Results The study sample included 3323 patients, with 1527 women. Stroke symptoms at presentation were similar in women and men, except that women were more likely to present with headaches and were less likely to have brain stem or cerebellar symptoms. There were no sex differences in the use of neuroimaging, thrombolysis, antithrombotic therapy, or consultations. Women were less likely than men to receive care on an acute stroke unit, but this difference was no longer significant after adjustment for age and other factors. Women were more likely than men to be discharged to long-term care and had greater disability at 6 months. Mortality and quality of life at 6 months were similar in women and men.
Conclusions Among patients participating in the RCSN, there were no major sex differences in stroke presentation or management. Compared with men, women were more often institutionalized and had a slightly worse functional status at 6 months after stroke.
Key Words: registries stroke womens health
| Introduction |
|---|
|
|
|---|
Numerous studies have documented sex differences in the presentation, management, and outcomes of patients with coronary artery disease. For example, compared with men, women with symptoms of coronary artery disease experience more atypical pain, are less likely to be referred for diagnostic testing, and may have higher mortality from coronary artery bypass surgery, although this may not be sustained long term.35 Although there is little published information on sex differences in stroke presentation and management, recent studies from Sweden and Europe have found differences in stroke symptoms and comorbid illness on presentation, lower use of some in-hospital investigations, and increased disability at 3 months after stroke in women.68 It is not known whether such differences exist in a North American setting nor whether women are less likely to receive interventions such as thrombolysis or care on an acute stroke unit.
We used data from the Registry of the Canadian Stroke Network (RCSN) to determine whether women and men with stroke were equally likely to receive evidence-based therapies for stroke, including thrombolysis, care on acute stroke unit, antithrombotic therapy, and warfarin for atrial fibrillation. We also compared in-hospital and 6-month outcomes in women and men.
| Methods |
|---|
|
|
|---|
Follow-up telephone interviews were attempted at 6 months after the index stroke admission on all patients surviving to discharge, regardless of discharge destination. During follow-up interviews, data were collected on survival, functional status, and quality of life. Functional status was measured using the Stroke Impact Scale-16 (SIS-16), which is derived from the SIS and is designed to measure physical functioning.10,11 The SIS has well-validated psychometric properties and includes a physical domain (comprised of 4 component domains of strength, hand function, mobility, and activities of daily living) as well as the domains of emotion, memory, communication, and social participation. The SIS-16 includes 16 questions from the SIS physical domain. Each question is rated on a scale of 1 (could not do at all) to 5 (not difficult at all), and the combined scores are transformed to a score from 0 (worst) to 100 (best). A difference of 10 to 15 points on the SIS-16 is considered clinically significant and correlates with a difference of 1 point in the modified Rankin scale.12 The SIS has been validated for proxy and telephone administration.13 Quality of life was measured using the Health Utilities Index (HUI) Mark 2/3, which provides a single-summary score of health-related quality of life, where a score of 0.00 indicates death and 1.00 indicates perfect health; negative scores (to a minimum of 0.36) are permitted to indicate health states considered worse than death.11 It includes questions related to the attributes of vision, hearing, speech, ambulation, dexterity, emotion, cognition, and pain. The HUI has been shown to be reliable, valid, and responsive to change, with differences in overall HUI scores of
0.03 considered clinically significant.14
We combined data from phases 1 and 2 of the registry and compared baseline demographics and stroke symptoms in women and men. We used
2 tests to compare the proportion of women and men who received care on an acute stroke unit and the proportion of women and men with ischemic stroke who received thrombolysis and antithrombotic agents. We used multiple logistic regression to adjust for age, stroke type (ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, or undefined stroke), stroke severity (as measured by the Canadian Neurological Scale [CNS] score), level of consciousness, comorbid illness (as measured by the Charlson comorbidity index score), marital status, and living situation.15,16 Because patient recruitment varied among study sites, the RCSN participation rate at each study center was included as a continuous variable in the modeling. Secondary analyses compared the proportion of women and men who underwent neuroimaging (computed tomography or MRI) and carotid imaging (Doppler ultrasound, catheter angiography, or magnetic resonance angiography) and who received inpatient consultations from occupational therapists, physiotherapists, speech-language pathologists, and neurologists. Other outcomes included in-hospital mortality and complications, length of stay, discharge destination, functional status at discharge (measured by the modified Rankin score), and 6-month mortality, SIS-16 scores, and HUI 2/3 scores. For SIS-16 scores, we used general linear modeling to compare outcomes in women and men with adjustment for age, comorbid illness, stroke type, and stroke severity. Cases missing data for the variable of interest were excluded from the analyses. SAS (version 8.02) was used for all analyses.
| Results |
|---|
|
|
|---|
|
Women and men were equally likely to be transported to hospital by ambulance, to arrive in the emergency department within 2 hours of stroke onset, and to have neuroimaging performed within 25 minutes of hospital arrival (Table 2). Women and men with ischemic stroke were equally likely to receive thrombolysis, even after adjustment for age and other risk factors (Table 2; also see Table 4). Women and men were equally likely to receive in-hospital assessments from occupational therapists, physiotherapists, social workers, and neurologists, although we did not examine the frequency or intensity of assessments. Women were less likely than men to receive care on an acute stroke unit (18% versus 21%; P=0.0232); however, this was no longer significant after adjustment for age, comorbidity, and other factors (adjusted odds ratio [OR], 0.940; 95% CI, 0.737 to 1.199; P=0.6189; see Table 4). Use of investigations, including neuroimaging, carotid imaging, and echocardiography, was similar in women and men; however, women were less likely to have lipids measured (Table 2). At discharge, women and men with ischemic stroke were equally likely to receive antithrombotic agents, including warfarin, for atrial fibrillation (Table 2).
|
The risk of in-hospital complications, including death, was similar in women and men, except that men were slightly more likely to develop pneumonia (Table 3). Women had a slightly longer median length of stay than men (11 versus 10 days; P=0.0108) and were more likely than men to be discharged to long-term care or a nursing home (10% versus 5%; P<0.0001), even after adjustment for age, comorbidity, and other risk factors (adjusted OR, 1.753; 95% CI, 1.129 to 2.719; P=0.0123; Tables 3 and 4
). Although the median Rankin score at discharge was similar in women and men, there was a trend toward a higher proportion of women with severe disability (Rankin score of 4 or 5) at discharge (30% versus 26%; P=0.0911).
|
|
Six-month follow-up data were available for 2790 patients. There was no difference in sex or stroke type among those with and without follow-up interviews; however, those lost to follow-up were slightly younger and were less likely to have been alert at the time of stroke onset. Six-month mortality was similar in women and men (14% versus 12%; P=0.1897), as was quality of life as measured by the HUI 2/3, with a median score of 0.9 for women and men. The median SIS-16 score was slightly lower in women (85.9 versus 92.2; P=0.0001; Table 3), and this was significant even after adjustment for age and stroke type.
| Discussion |
|---|
|
|
|---|
The findings of sex differences in demographics, length of stay, and discharge destination after stroke admission are consistent with previous studies, which have shown that women with stroke tend to be older and less likely to have social supports than their male counterparts.18 However, our findings differ from recent publications from other stroke databases, which have documented sex differences in stroke presentation, with an increased frequency of symptoms such as aphasia and dysphagia in women.6,7 Previous studies have also suggested lower use of investigations and therapies in women, including lower use of computed tomography, carotid imaging, and antithrombotic agents.6,7,19 The discrepant findings among different studies may reflect differences in the study populations or variations in practice patterns among jurisdictions. For example, we had few patients >85 years of age, a subgroup in which management has been shown to differ in women and men,19 and our participating institutions were primarily tertiary care hospitals with specialized stroke care resources and expertise, in which stroke care delivery patterns may not reflect general practice in Canada.
The most common presenting symptoms for women and men were weakness, sensory symptoms, brain stem or cerebellar symptoms such as vertigo, and headache, which are consistent with the stroke warning signs taught in public awareness campaigns by organizations such as the Heart and Stroke Foundation of Canada and the American Stroke Association. This suggests that the current public education initiatives are appropriate for women and men. However, health care providers should be aware of the higher frequency of headache as a presenting symptom in women, related in part to the higher frequency of subarachnoid hemorrhage as the cause of stroke in women.
Despite a similar stroke severity on presentation, as measured by the CNS, and a similar Rankin score at discharge, women stayed in hospital on average 1 day longer than men and were more likely to be discharged to long-term care. This is consistent with previous studies and is likely explained by a poorer preadmission functional status in women (women were slightly less likely than men to be completely independent before admission) and fewer social supports, with more women than men being widowed and living alone. In addition, women may have more disability after stroke: although the median Rankin score at discharge was similar in women and men, there was a trend toward a higher proportion of women with severe disability at discharge. Although mortality and quality of life were similar in women and men at 6 months after stroke, women had a slightly worse functional status, as measured by the SIS-16, with a median score that was 6.3 points lower than that of men. This difference corresponds to
0.5 points on the Rankin scale, a difference that may not be clinically significant for an individual patient but that is likely to be relevant at a population level.12
This study has a number of limitations. First, patient or surrogate consent was required for participation in the RCSN, which resulted in the exclusion of some patients with severe or fatal stroke who were unable to give consent, as well as those with minor stroke or transient ischemic attack who were discharged before they could be approached by the study coordinator. 20 Thus, the results of our study are generalizable mainly to the subgroup of patients with moderate severity strokes. Although overall consent rates were similar in women and men, it is possible that there were differences in the characteristics of men and women who did not consent to data collection (for example, women may have been over-represented in the older patients with more severe strokes), and there may have been sex differences in the management and outcomes of this subgroup of patients that were not captured in this study. Second, participating hospitals were primarily tertiary care institutions with specific stroke care expertise and resources, and the care provided to women and men at these sites may not be representative of stroke care delivery at other types of institutions. However, administrative data show that
20% of all Canadian stroke patients are admitted to these institutions (J.V. Tu, unpublished data, 2002), suggesting that our results are applicable to a substantial proportion of the population. In addition, although stroke care in general is likely to be different in institutions that did and did not participate in the RCSN, there is no specific reason to suspect that care for women would be systematically different at different types of institutions. Finally, we do not have detailed information on interventions such as the type of rehabilitation provided or other outcomes such as patient satisfaction.
In summary, we found that stroke presentation and management were similar in women and men participating in the RCSN. However, the longer length of stay and greater disability in women confirm the personal and societal burden of stroke in this population. Future research should focus on exploring reasons for and potential solutions to these differences in outcomes.
| Appendix |
|---|
|
|
|---|
Queen Elizabeth II Health Sciences Centre, Halifax, NS
S. Phillips, MD (principal investigator), G. Gubitz, MD (principal investigator), W. Simpkin, RN (coordinator).
Saint John Regional Hospital, St. John, NB
P. Bailey, MD (principal investigator), P. Cook, RN (coordinator), Shelly Allward, RN (coordinator).
Hôpital Notre-Dame du CHUM, Montreal, QC
L.H. Lebrun, MD (principal investigator), M.P, Desrochers, RN (coordinator), L. Mercille, RN (coordinator).
Hôpital de lEnfant-Jesus, Quebec City, QC
D. Simard, MD (principal investigator), A. Mackey, MD (principal investigator), S. Dube, RN (coordinator), B. Leger, RN (coordinator), A. Hache, RN (coordinator).
Hôpital Charles le Moyne, Greenfield Park, QC
L. Berger, MD (principal investigator), L. Moisan, RN (coordinator), Y. Serraspino, RN (coordinator), D. Truong, RN (coordinator)
Montreal General Hospital and SMBD-Jewish General Hospital, Montreal, QC
R. Cote, MD (principal investigator), J. Minuk, MD (principal investigator), C. Wong, RN (coordinator).
Sunnybrook and Womens College Health Sciences Centre, Toronto, ON
S. Black, MD (principal investigator), N. Jiang (coordinator), J. Bray (coordinator), M. Kerr-Taylor, RN (coordinator).
University Health Network/Toronto Western Hospital, Toronto, ON
F. Silver, MD (principal investigator), P. Urzua, RN (coordinator), G. Gutierrez, RN (coordinator), R. Wiegner, RN (coordinator).
London Health Sciences Centre, London, ON
V. Hachinski, MD (principal investigator), N. Absolon, RN (coordinator), L. Cotton, RN (coordinator).
The Ottawa Hospital, Ottawa, ON
A. Douen, MD (principal investigator), M. Sharma, MD (principal investigator), N. Pageau, RN (coordinator), M. Savage, RN (coordinator).
Kingston General Hospital, Kingston, ON
D. Howse, MD (principal investigator), D. Brunet, MD (principal investigator), S. Weatherby, RN (coordinator).
Hamilton Health Sciences Centre, Hamilton, ON
W. Oczkowski, MD (principal investigator), N. Pyette, RN (coordinator), L. Gould, RPN (coordinator).
Trillium Health Sciences Centre, Mississauga, ON
D. Selchen, MD (principal investigator), H. Hinks, RN (coordinator), T. Stokes, RN (coordinator).
Winnipeg Regional Health Authority, Winnipeg, MB
B. Anderson, MD (principal investigator), D. Gladish, RN (coordinator), A. Gousseau, RN (coordinator), P. Pikl, RN (coordinator).
Royal University Hospital, Saskatoon, SK
C. Voll, MD (principal investigator), S. Bishop, RN (coordinator), L. Schmidt, RN (coordinator), B. Kwiatkowski, RN (coordinator).
Foothills Medical Centre, Calgary, AB
M. Hill, MD (principal investigator), L. Sinclair, RN (coordinator), M. Schebel, RN (coordinator), A. Cole-Haskayne, RN (coordinator).
University of Alberta Hospital, Edmonton, AB
A. Shuaib, MD (principal investigator), A. Nasser, RN (coordinator).
Lions Gate Hospital, North Vancouver, BC
D. Cameron, MD (principal investigator), C. Tadey, RN (coordinator).
Vancouver General Hospital, Vancouver, BC
P. Teal, MD (principal investigator), T. Steele, BSN, RN (coordinator).
St. Pauls Hospital, Vancouver, BC
D. Johnston, MD (principal investigator), M. Wong, MD (principal investigator), H. Connolly, RN (coordinator).
Capital Health Region, Victoria, BC
A. Penn, MD (principal investigator), M. Laporte, RN (coordinator).
| Acknowledgments |
|---|
| Footnotes |
|---|
Received November 1, 2004; revision received December 20, 2004; accepted December 24, 2004.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. M. Kent, A. M. Buchan, and M. D. Hill The gender effect in stroke thrombolysis: Of CASES, controls, and treatment-effect modification Neurology, September 30, 2008; 71(14): 1080 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Saposnik, R. Cote, S. Phillips, G. Gubitz, N. Bayer, J. Minuk, S. Black, and for the Stroke Outcome Research Canada (SORCan) Wo Stroke Outcome in Those Over 80: A Multicenter Cohort Study Across Canada Stroke, August 1, 2008; 39(8): 2310 - 2317. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Saposnik, M. D. Hill, M. O'Donnell, J. Fang, V. Hachinski, M. K. Kapral, and on behalf of the investigators of the Registry of Variables Associated With 7-Day, 30-Day, and 1-Year Fatality After Ischemic Stroke Stroke, August 1, 2008; 39(8): 2318 - 2324. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Arrich, M. Mullner, W. Lalouschek, S. Greisenegger, R. Crevenna, and H. Herkner Influence of Socioeconomic Status and Gender on Stroke Treatment and Diagnostics Stroke, July 1, 2008; 39(7): 2066 - 2072. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Bushnell, J. Lee, P. W. Duncan, L. K. Newby, and L. B. Goldstein Impact of Comorbidities on Ischemic Stroke Outcomes in Women Stroke, July 1, 2008; 39(7): 2138 - 2140. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Reid, D. Dai, G. J. Gubitz, M. K. Kapral, C. Christian, and S. J. Phillips Gender Differences in Stroke Examined in a 10-Year Cohort of Patients Admitted to a Canadian Teaching Hospital Stroke, April 1, 2008; 39(4): 1090 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Prabhakaran, C. B. Wright, M. Yoshita, R. Delapaz, T. Brown, C. DeCarli, and R. L. Sacco Prevalence and determinants of subclinical brain infarction: The Northern Manhattan Study Neurology, February 5, 2008; 70(6): 425 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Gargano, S. Wehner, and M. Reeves Sex Differences in Acute Stroke Care in a Statewide Stroke Registry Stroke, January 1, 2008; 39(1): 24 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Gray, N. Sprigg, P. M.W. Bath, G. Boysen, P. P. De Deyn, D. Leys, D. O'Neill, E. B. Ringelstein, and for the TAIST Investigators Sex Differences in Quality of Life in Stroke Survivors: Data From the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST) Stroke, November 1, 2007; 38(11): 2960 - 2964. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Saposnik, A. Baibergenova, M. O'Donnell, M. D. Hill, M. K. Kapral, V. Hachinski, and On behalf of the Stroke Outcome Research Canada (S Hospital volume and stroke outcome: Does it matter? Neurology, September 11, 2007; 69(11): 1142 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Gargano, M. J. Reeves, and for the Paul Coverdell National Acute Stroke Regis Sex Differences in Stroke Recovery and Stroke-Specific Quality of Life: Results From a Statewide Stroke Registry Stroke, September 1, 2007; 38(9): 2541 - 2548. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Foerch, B. Misselwitz, M. Humpich, H. Steinmetz, T. Neumann-Haefelin, M. Sitzer, and for the Arbeitsgruppe Schlaganfall Hessen Sex Disparity in the Access of Elderly Patients to Acute Stroke Care Stroke, July 1, 2007; 38(7): 2123 - 2126. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hodgson, P. Lindsay, and F. Rubini Can Mass Media Influence Emergency Department Visits for Stroke? Stroke, July 1, 2007; 38(7): 2115 - 2122. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Mayo, L. Nadeau, S. S. Daskalopoulou, and R. Cote The evolution of stroke in Quebec: A 15-year perspective Neurology, April 3, 2007; 68(14): 1122 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arnold, L. Kappeler, K. Nedeltchev, C. Brekenfeld, U. Fischer, B. Keserue, L. Remonda, G. Schroth, and H. P. Mattle Recanalization and Outcome After Intra-Arterial Thrombolysis in Middle Cerebral Artery and Internal Carotid Artery Occlusion: Does Sex Matter? Stroke, April 1, 2007; 38(4): 1281 - 1285. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.S.V. Elkind, S. Prabhakaran, J. Pittman, W. Koroshetz, M. Jacoby, K. C. Johnston, and for the GAIN Americas Investigators Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke Neurology, March 13, 2007; 68(11): 842 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Carandang, S. Seshadri, A. Beiser, M. Kelly-Hayes, C. S. Kase, W. B. Kannel, and P. A. Wolf Trends in Incidence, Lifetime Risk, Severity, and 30-Day Mortality of Stroke Over the Past 50 Years JAMA, December 27, 2006; 296(24): 2939 - 2946. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Kent and M. D. Hill Differences in Response to Reperfusion Therapies in Acute Stroke Between Men and Women: Mediated by Sex or by Chance? Stroke, December 1, 2006; 37(12): 2878 - 2879. [Full Text] [PDF] |
||||
![]() |
S. Paolucci, M. Bragoni, P. Coiro, D. De Angelis, F. R. Fusco, D. Morelli, V. Venturiero, and L. Pratesi Is Sex a Prognostic Factor in Stroke Rehabilitation?: A Matched Comparison Stroke, December 1, 2006; 37(12): 2989 - 2994. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Hill, D. M. Kent, J. Hinchey, H. Rowley, A. M. Buchan, L. R. Wechsler, R. T. Higashida, N. J. Fischbein, W. P. Dillon, M. Gent, et al. Sex-Based Differences in the Effect of Intra-Arterial Treatment of Stroke: Analysis of the PROACT-2 Study Stroke, September 1, 2006; 37(9): 2322 - 2325. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Kent, M. D. Hill, S. I. Savitz, and M. Selim Gender Differences in tPA-Related Arterial Recanalization * Response: Stroke, December 1, 2005; 36(12): 2529 - 2530. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||